Switching Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance
Clin Diabetes
.
2020 Oct;38(4):390-402.
doi: 10.2337/cd19-0100.
Authors
Jaime P Almandoz
1
,
Ildiko Lingvay
1
,
Javier Morales
2
,
Carlos Campos
3
Affiliations
1
UT Southwestern Medical Center, Dallas, TX.
2
Hofstra/Northwell University, New York, NY.
3
University of Texas Health Science Center, San Antonio, TX.
PMID:
33132510
PMCID:
PMC7566932
DOI:
10.2337/cd19-0100
No abstract available